Varengold Bank AG Net Assets
Varengold Bank AG net assets. Based on the latest financial reports, Varengold Bank AG (VG8) has net assets worth €84.96 Million EUR (≈ $99.33 Million USD) as of June 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.12 Billion ≈ $1.31 Billion USD) and total liabilities (€1.03 Billion ≈ $1.21 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Varengold Bank AG (VG8) net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €84.96 Million |
| % of Total Assets | 7.59% |
| Annual Growth Rate | 24.79% |
| 5-Year Change | 132.53% |
| 10-Year Change | 557.5% |
| Growth Volatility | 138.63 |
Net Assets of Varengold Bank AG (2013–2023)
Net assets of Varengold Bank AG from 2013 to 2023. This chart illustrates how Varengold Bank AG's net assets have evolved over time, based on quarterly financial data. See Varengold Bank AG balance sheet quality to measure how much of total assets are equity-financed.
Annual Net Assets for Varengold Bank AG (2013–2023)
The table below shows the annual net assets of Varengold Bank AG from 2013 to 2023. For live market cap and overall valuation, see Varengold Bank AG stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €79.41 Million ≈ $92.84 Million |
+22.38% |
| 2022-12-31 | €64.89 Million ≈ $75.86 Million |
+16.22% |
| 2021-12-31 | €55.83 Million ≈ $65.27 Million |
+44.39% |
| 2020-12-31 | €38.67 Million ≈ $45.20 Million |
+13.22% |
| 2019-12-31 | €34.15 Million ≈ $39.93 Million |
+37.86% |
| 2018-12-31 | €24.77 Million ≈ $28.96 Million |
+34.19% |
| 2017-12-31 | €18.46 Million ≈ $21.58 Million |
+35.96% |
| 2016-12-31 | €13.58 Million ≈ $15.87 Million |
+465.82% |
| 2015-12-31 | €2.40 Million ≈ $2.81 Million |
-80.13% |
| 2014-12-31 | €12.08 Million ≈ $14.12 Million |
+39.19% |
| 2013-12-31 | €8.68 Million ≈ $10.14 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Varengold Bank AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3011899279.0% over the analyzed period, indicating profitable operations and earnings retention.
Varengold Bank AG Net Assets Breakdown (December 2023)
Varengold Bank AG net assets breakdown by equity component as of December 2023.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €24.66 Million | 31.05% |
| Other Components | €54.75 Million | 68.95% |
| Total Equity | €79.41 Million | 100.00% |
Varengold Bank AG Competitors by Market Cap
The table below lists competitors of Varengold Bank AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Inventec Besta Co Ltd
TW:8201
|
$29.57 Million |
|
Matriks Bilgi Dagitim Hizmetleri AS
IS:MTRKS
|
$29.59 Million |
|
PT Sarimelati Kencana Tbk
JK:PZZA
|
$29.59 Million |
|
Allegiant Gold Ltd
V:AUAU
|
$29.59 Million |
|
SoftOx Solutions AS
OL:SOFTX
|
$29.56 Million |
|
Apex Equity Holdings Bhd
KLSE:5088
|
$29.56 Million |
|
GeneReach Biotechnology
TWO:4171
|
$29.56 Million |
|
Cubex Tubings Limited
NSE:CUBEXTUB
|
$29.55 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Varengold Bank AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 64,888,300 to 79,411,400, a change of 14,523,100 (22.4%).
- Net income of 14,523,078 contributed positively to equity growth.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €14.52 Million | +18.29% |
| Other Changes | €22.90 | +0.0% |
| Total Change | €- | 22.38% |
Book Value vs Market Value Analysis
This analysis compares Varengold Bank AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.36x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.71x to 0.36x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €3.97 | €2.82 | x |
| 2018-12-31 | €2.66 | €2.82 | x |
| 2019-12-31 | €3.40 | €2.82 | x |
| 2020-12-31 | €3.85 | €2.82 | x |
| 2021-12-31 | €5.56 | €2.82 | x |
| 2022-12-31 | €6.46 | €2.82 | x |
| 2023-12-31 | €7.91 | €2.82 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Varengold Bank AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 18.29%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 23.70%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 17.05x
- Recent ROE (18.29%) is above the historical average (-48.01%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -42.42% | -73.51% | 0.09x | 6.12x | €-4.55 Million |
| 2014 | 1.73% | 1.42% | 0.04x | 29.24x | €-998.38K |
| 2015 | -550.80% | -102.83% | 0.02x | 250.54x | €-13.46 Million |
| 2016 | -10.94% | -9.58% | 0.03x | 45.21x | €-2.84 Million |
| 2017 | 0.13% | 0.15% | 0.03x | 24.12x | €-1.82 Million |
| 2018 | 2.08% | 2.47% | 0.04x | 21.43x | €-1.96 Million |
| 2019 | 4.73% | 7.50% | 0.03x | 20.71x | €-1.80 Million |
| 2020 | 4.43% | 6.48% | 0.03x | 25.74x | €-2.15 Million |
| 2021 | 30.75% | 32.87% | 0.04x | 26.27x | €11.58 Million |
| 2022 | 13.96% | 11.42% | 0.06x | 21.90x | €2.57 Million |
| 2023 | 18.29% | 23.70% | 0.05x | 17.05x | €6.58 Million |
Industry Comparison
This section compares Varengold Bank AG's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Varengold Bank AG (VG8) | €84.96 Million | -42.42% | 12.17x | $29.57 Million |
| Covestro AG (1COV) | $6.68 Billion | -3.98% | 1.04x | $11.10 Billion |
| CENTESSA PHARMACEUTICALS (260) | $401.55 Million | -58.71% | 0.44x | $5.35 Billion |
| 2invest AG (2INV) | $61.58 Million | -34.16% | 0.01x | $70.69 Million |
| COINSHARES I. LS-000247 (3TW) | $-1.41K | 0.00% | 0.00x | $472.53 Million |
| Adaptimmune Therapeutics plc (473A) | $123.64 Million | -110.94% | 0.47x | $42.94 Million |
| KINGMAN MINERALS LTD. (47A) | $1.72 Million | -14.34% | 0.35x | $4.05K |
| GENOR BIOPHARMA DL-00002 (67N0) | $2.49 Billion | -34.70% | 0.15x | $93.97 Million |
| BENO Holding AG (BENH) | $16.45 Million | 13.33% | 2.75x | $72.92K |
| Biotest Aktiengesellschaft (BIO) | $253.37 Million | 11.10% | 1.34x | $976.15 Million |
| Biotest Aktiengesellschaft (BIO3) | $110.79 Million | 17.87% | 2.36x | $656.94 Million |
About Varengold Bank AG
Varengold Bank AG provides various marketplace and transaction/commercial banking products and services in Germany. The company offers lending and fronting services; funding; international payment transaction; and call and fixed term deposits. It also offers bank guarantees and debt and equity capital market products. The company was formerly known as Varengold Wertpapierhandelsbank AG and change… Read more